Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

[1]  Yoav Mayshar,et al.  Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.

[2]  Stine H. Kresse,et al.  Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours , 2010, BMC Research Notes.

[3]  F. Tanaka,et al.  FRS2β, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding , 2010, Oncogene.

[4]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[5]  R. Lahesmaa,et al.  High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity , 2010, Nature Biotechnology.

[6]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[7]  M. Peschanski,et al.  Human embryonic stem cells reveal recurrent genomic instability at 20q11.21 , 2008, Nature Biotechnology.

[8]  K. Sermon,et al.  Recurrent chromosomal abnormalities in human embryonic stem cells , 2008, Nature Biotechnology.

[9]  Nancy F. Hansen,et al.  Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry , 2008, Nature.

[10]  M. Mansukhani,et al.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression , 2008, Genes, chromosomes & cancer.

[11]  T. Anantharaman,et al.  Copy Number Variant Analysis of Human Embryonic Stem Cells , 2008, Stem cells.

[12]  J. Fox.  FDA scrutinizes human stem cell therapies , 2008, Nature Biotechnology.

[13]  P. Wernet,et al.  Oct4 and its pseudogenes confuse stem cell research. , 2007, Cell stem cell.

[14]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[15]  E. Jordanova,et al.  Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma , 2007, Melanoma research.

[16]  E. Blennow,et al.  In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells , 2006, Journal of cellular biochemistry.

[17]  S. Ishikawa,et al.  Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays , 2006, Oncogene.

[18]  D. Kemp,et al.  Adult Tissue-specific Expression of a Dppa3-derived Retrogene Represents a Postnatal Transcript of Pluripotent Cell Origin* , 2006, Journal of Biological Chemistry.

[19]  A. Chakravarti,et al.  Genomic alterations in cultured human embryonic stem cells , 2005, Nature Genetics.

[20]  L. Chin,et al.  High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  G. Chirn,et al.  Multiple Retropseudogenes from Pluripotent Cell-specific Gene Expression Indicates a Potential Signature for Novel Gene Identification* , 2005, Journal of Biological Chemistry.

[22]  Steven L. Stice,et al.  Preserving the genetic integrity of human embryonic stem cells , 2005, Nature Biotechnology.

[23]  P. Holland,et al.  Eleven daughters of NANOG. , 2004, Genomics.

[24]  N. Carter,et al.  High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization , 2004, Oncogene.

[25]  Atsushi Yoshiki,et al.  An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene , 2003, Nature.

[26]  R. Lothe,et al.  New insights into testicular germ cell tumorigenesis from gene expression profiling. , 2002, Cancer research.

[27]  P. Meltzer,et al.  Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma. , 1996, Blood.

[28]  P. Meltzer,et al.  Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.

[29]  P. Meltzer,et al.  Molecular cytogenetic analysis of i(12p)‐negative human male germ cell tumors , 1993, Genes, chromosomes & cancer.

[30]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[31]  N. B. Atkin,et al.  SPECIFIC CHROMOSOME CHANGE, i(12p), IN TESTICULAR TUMOURS? , 1982, The Lancet.

[32]  J. Thomson,et al.  Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells , 2004, Nature Biotechnology.